{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:20:08Z","timestamp":1790515208611,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1093017"],"award-info":[{"award-number":["APP1093017"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.pathol.2021.12.289","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T17:04:22Z","timestamp":1646240662000},"page":"533-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7610-3984","authenticated-orcid":false,"given":"Andrew J.","family":"Colebatch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Paver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael A.","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2816-2496","authenticated-orcid":false,"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8894-3545","authenticated-orcid":false,"given":"Georgina V.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Wilmott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-0013","authenticated-orcid":false,"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.12.289_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.47102\/annals-acadmedsg.V33N4p3S","article-title":"Melanocytic lesions of the face: diagnostic pitfalls","volume":"33","author":"McCarthy","year":"2004","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.pathol.2021.12.289_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pathol.2017.09.002","article-title":"Trajectories of premalignancy during the journey from melanocyte to melanoma","volume":"50","author":"Colebatch","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2021.12.289_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","article-title":"Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution","volume":"34","author":"Shain","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2021.12.289_bib4","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2021.12.289_bib5","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.aao0535","article-title":"Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism","volume":"357","author":"Chiba","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.pathol.2021.12.289_bib6","series-title":"WHO Classification of Tumours: Skin Tumours","author":"Elder","year":"2019"},{"key":"10.1016\/j.pathol.2021.12.289_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","article-title":"High frequency of BRAF mutations in nevi","volume":"33","author":"Pollock","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2021.12.289_bib8","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.jid.2018.12.033","article-title":"Molecular genomic profiling of melanocytic nevi","volume":"139","author":"Colebatch","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pathol.2021.12.289_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pcmr.12412","article-title":"Genetics of melanocytic nevi","volume":"28","author":"Roh","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pathol.2021.12.289_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069639","article-title":"NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi","volume":"8","author":"Tschandl","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2021.12.289_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2021.12.289_bib12","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/s41467-020-16276-8","article-title":"Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours","volume":"11","author":"Johansson","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2021.12.289_bib13","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1038\/s41467-020-18988-3","article-title":"Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity","volume":"11","author":"Newell","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2021.12.289_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ijc.31791","article-title":"Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility","volume":"144","author":"Wilmott","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2021.12.289_bib15","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1038\/s41467-019-11107-x","article-title":"Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets","volume":"10","author":"Newell","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2021.12.289_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature17661","article-title":"Nucleotide excision repair is impaired by binding of transcription factors to DNA","volume":"532","author":"Sabarinathan","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2021.12.289_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAS.0000000000001406","article-title":"Molecular profiling of noncoding mutations distinguishes nevoid melanomas from mitotically active nevi in pregnancy","volume":"44","author":"Jackett","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.12.289_bib18","doi-asserted-by":"crossref","first-page":"66569","DOI":"10.18632\/oncotarget.11892","article-title":"Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies","volume":"7","author":"Colebatch","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2021.12.289_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","article-title":"The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia","volume":"9","author":"Bastian","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.pathol.2021.12.289_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050120","article-title":"Improving melanoma classification by integrating genetic and morphologic features","volume":"5","author":"Viros","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.pathol.2021.12.289_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.0493","article-title":"Association between NRAS and BRAF mutational status and melanoma-specific survival among patients with higher-risk primary melanoma","volume":"1","author":"Thomas","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.pathol.2021.12.289_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bjd.13829","article-title":"Mutational status of naevus-associated melanomas","volume":"173","author":"Shitara","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pathol.2021.12.289_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pathol.2021.12.289_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41568-021-00371-z","article-title":"Non-coding driver mutations in human cancer","volume":"21","author":"Elliott","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2021.12.289_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","article-title":"Analyses of non-coding somatic drivers in 2,658 cancer whole genomes","volume":"578","author":"Rheinbay","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2021.12.289_bib26","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1038\/s41467-018-05064-0","article-title":"ETS transcription factors induce a unique UV damage signature that drives recurrent mutagenesis in melanoma","volume":"9","author":"Mao","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2021.12.289_bib27","doi-asserted-by":"crossref","first-page":"24196","DOI":"10.1073\/pnas.1907860116","article-title":"Genomic sites hypersensitive to ultraviolet radiation","volume":"116","author":"Premi","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2021.12.289_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A\u00a0landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2021.12.289_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2021.12.289_bib30","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1158\/0008-5472.CAN-14-1232-T","article-title":"The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF","volume":"74","author":"Watson","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2021.12.289_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm3979","article-title":"Regulation of RAF protein kinases in ERK signalling","volume":"16","author":"Lavoie","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pathol.2021.12.289_bib32","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41379-020-0510-7","article-title":"Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles","volume":"33","author":"Williams","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.12.289_bib33","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1111\/1346-8138.15849","article-title":"Clinical response to a MEK inhibitor in a patient with metastatic melanoma harboring an RAF1 gene rearrangement detected by cancer gene panel testing","volume":"48","author":"Nakama","year":"2021","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.pathol.2021.12.289_bib34","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1172\/JCI123089","article-title":"Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion","volume":"129","author":"McEvoy","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2021.12.289_bib35","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41379-019-0445-z","article-title":"Spitz melanoma is a distinct subset of spitzoid melanoma","volume":"33","author":"Raghavan","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.12.289_bib36","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.18632\/oncotarget.2048","article-title":"A\u00a0highly recurrent RPS27 5'UTR mutation in melanoma","volume":"5","author":"Dutton-Regester","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2021.12.289_bib37","first-page":"203","article-title":"Increased serum level of RPMPS-1\/S27 protein in patients with various types of cancer is useful for the early detection, prevention and therapy","volume":"9","author":"Fernandez-Pol","year":"2012","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.pathol.2021.12.289_bib38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/pcmr.12841","article-title":"Functional analysis of RPS27 mutations and expression in melanoma","volume":"33","author":"Floristan","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pathol.2021.12.289_bib39","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/pcmr.12228","article-title":"Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4\/6 inhibitor PD0332991 in melanoma cell lines","volume":"27","author":"Young","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pathol.2021.12.289_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ccell.2018.05.014","article-title":"Bi-allelic loss of CDKN2A initiates melanoma invasion via BRN2 activation","volume":"34","author":"Zeng","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2021.12.289_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pathol.2021.12.289_bib42","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00018-011-0878-0","article-title":"Genetic alterations of PTEN in human melanoma","volume":"69","author":"Aguissa-Toure","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pathol.2021.12.289_bib43","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/cancers12030742","article-title":"The role of PTEN loss in immune escape, melanoma prognosis and therapy response","volume":"12","author":"Cabrita","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pathol.2021.12.289_bib44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to T cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pathol.2021.12.289_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc.2017.117","article-title":"Impact of oncogenic pathways on evasion of antitumour immune responses","volume":"18","author":"Spranger","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2021.12.289_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/excr.1999.4686","article-title":"Function of the c-Myc oncogenic transcription factor","volume":"253","author":"Dang","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pathol.2021.12.289_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00109-016-1452-x","article-title":"C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc\/snail\/Bax signaling","volume":"95","author":"Lin","year":"2017","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.pathol.2021.12.289_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00280-015-2796-6","article-title":"Metastatic melanoma cells with BRAF G469A mutation: nab-paclitaxel better than vemurafenib?","volume":"76","author":"Porcelli","year":"2015","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:55:00Z","timestamp":1778651700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302522000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0031302522000617"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.12.289","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.12.289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}